Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)

NCT00000559 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
Postmenopause

Interventions

DRUG: estrogen replacement therapy
DRUG: hormone replacement therapy
DRUG: estradiol
DRUG: medroxyprogesterone

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)